Correlation between Ischaemia-modified Albumin and Intermediate-density Lipoprotein in Haemodialysis Patients with End-stage Renal Disease

By Kotani K   Kimura S   Kinugasa E   Ogata H   Caccavello R   Taniguchi N   Gugliucci A  

The Journal of International Medical Research, Vol. 39, Iss. 4, 2011-07 ,pp. : 1541-1545

Field House Publishing

Access to resources Recommend Favorite

Sevelamer Hydrochloride: A Review of its Use for Hyperphosphataemia in Patients with End-Stage Renal Disease on Haemodialysis

By Goldsmith David R.   Scott Lesley J.   Cvetković Risto S.   Plosker Greg L.  

Drugs, Vol. 68, Iss. 1, 2008-01 ,pp. : 85-104

Adis International

Access to resources Recommend Favorite

Intravenous N -Acetylcysteine during Haemodialysis Reduces the Plasma Concentration of Homocysteine in Patients with End-Stage Renal Disease

By Thaha Mochammad  

Clinical Drug Investigation, Vol. 26, Iss. 4, 2006-01 ,pp. : 195-202

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of Rosiglitazone in Patients with End-stage Renal Disease

By Thompson-Culkin K   Zussman B   Miller AK   Freed MI  

The Journal of International Medical Research, Vol. 30, Iss. 4, 2002-07 ,pp. : 391-399

Field House Publishing

Access to resources Recommend Favorite

Asymmetric Dimethylarginine: a Novel Cardiovascular Risk Factor in End-stage Renal Disease

By Alsagaff M Yusuf   Thaha M   Aminuddin M   Yogiarto RM   Yogiantoro M   Tomino Y  

The Journal of International Medical Research, Vol. 40, Iss. 1, 2012-01 ,pp. : 340-349

Field House Publishing

Access to resources Recommend Favorite